Saskia Bulk and Nicole W.J. Bulkmans have contributed equally to this manuscript. Bulk performed the analyses and prepared the manuscript. N.W.J. Bulkmans was responsible for the data collection. J. Berkhof was responsible for the conception of the study and statistical methods. P.J.F. Snijders was responsible for the virology determinations. C.J.L.M. Meijer was the principal investigator of the project, and had access to all data and final responsibility for the decision to submit for publication. All authors participated in the preparation of the design of the study, interpretation of data, writing of the manuscript and approved the final version of the manuscript.
Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months†
Article first published online: 12 MAR 2007
Copyright © 2007 Wiley-Liss, Inc.
International Journal of Cancer
Volume 121, Issue 2, pages 361–367, 15 July 2007
How to Cite
Bulk, S., Bulkmans, N. W.J., Berkhof, J., Rozendaal, L., P. Boeke, A. J., Verheijen, R. H.M., Snijders, P. J.F. and Meijer, C. J.L.M. (2007), Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months. Int. J. Cancer, 121: 361–367. doi: 10.1002/ijc.22677
POBASCAM study collaborators other than authors: Dr. K. V Groningen (Spaarne Ziekenhuis, Hoofddorp), Dr. W. Ruitinga (Kennemer Gasthuis, Haarlem), Dr. M.E. Boon (Leiden Cytology and Pathology Laboratory, Leiden), Dr. M. van Ballegooijen (Department of Public Health and Social Medicine, Erasmus University Rotterdam), Dr. F.J. Voorhorst and Dr. F.J. van Kemenade (Unit cytopathology, VU University Medical Center, Amsterdam).
- Issue published online: 18 MAY 2007
- Article first published online: 12 MAR 2007
- Manuscript Revised: 23 JAN 2007
- Manuscript Received: 4 SEP 2006
- ZonMW (Zorg Onderzoek Nederland, Netherlands Organisation for Health Research and Development). Grant Number: 30-05220, 2200.0089
- 15Carcinoma of the cervix uteri. J Epidemiol Biostat 1998; 3: 5–34., , , , , , , .
- 16Premalignant and malignant squamous lesions of the cervix. In: FoxH,WellsM,Haines,Taylor, eds. Obstetrical and gynaecological pathology. New York: Chruchill Livingstone, 1995. 292–7..
- 22Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus dna-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003; 188: 1401–5., , , .
- 27Randomized controlled trial of human papillomavirus testing versus pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the canadian cervical cancer screening trial (CCCaST). Int J Cancer 2006; 119: 615–23., , , , , , .